SANDERCOCK BRETT (Chief Financial Officer) sold 3.4% of their position (3K shares) of RESMED INC on the open market
Open‑market sale worth $742.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/4/2025ACC: 0000943819-25-000092
Officer· Chief Financial Officer
Since Mar 2026
-3K
Net shares
Net seller
$742.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2K acquired · 5K disposed
Non-Derivative Transactions2
ResMed Common Stock
Direct
Shares
+2K
Price / share
$101.64
Trade value
$203.28K
% of position
2.3%
11/3/2025
86.75K→88.75K
ResMed Common Stock
Direct
Shares
−3K
Price / share
$247.54
Trade value
$742.62K
% of position
3.4%
11/3/2025
88.75K→85.75K
Total
Net shares
−1K
Net value
-$539.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock Direct | 11/3/2025 | M · Option Exercise | +2K | $101.64 | $203.28K | 2.3% | 86.75K | 88.75K |
| ResMed Common Stock Direct | 11/3/2025 | S · Sale | −3K | $247.54 | $742.62K | 3.4% | 88.75K | 85.75K |
| Total | −1K | -$539.34K | ||||||
Derivative Transactions1
ResMed Common Stock Options
Direct
Converts to
ResMed Common Stock
2K shares
Shares
−2K
Strike price
101.64
Held after
0.00
Exercisable
—
11/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| ResMed Common Stock Options Direct | ResMed Common Stock2K shares | 11/3/2025 | M · Option Exercise | −2K | 101.64 | — | 0.00 |